- ►bccrc.ca [PDF] H Yamaguchi, RT Calado, H Ly, S Kajigaya, … - New England Journal of Medicine, 2005 - content.nejm.org Results Five heterozygous, nonsynonymous mutations (which cause an amino acid
change in the corresponding protein) were identified in TERT, the gene for the
telomerase reverse transcriptase catalytic enzyme, among seven unrelated ... Cited by 207 - Related articles - All 17 versions
- ►bloodjournal.org [PDF] A Conconi, G Martinelli, C Thieblemont, AJM … - Blood, 2003 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 165 - Related articles - BL Direct - All 6 versions
- ►annals.org [PDF] DE Dunn, P Tanawattanacharoen, P Boccuni, … - Annals of Internal Medicine, 1999 - Am Coll Physicians Daniel E. Dunn, MD, PhD; Patcharin Tanawattanacharoen, MD; Piernicola Boccuni,
MD; Shoichi Nagakura, MD, PhD; Spencer W. Green, BS; Martha R. Kirby, BA; Mysore
S. Anil Kumar, MD; Stephen Rosenfeld, MD; and Neal S. Young, MD Cited by 155 - Related articles - BL Direct - All 4 versions
- ►hematologylibrary.org NS Young, RT Calado, P Scheinberg - Blood, 2006 - bloodjournal.hematologylibrary.org Aplastic anemia, an unusual hematologic disease, is the paradigm of the human
bone marrow failure syndromes. Almost universally fatal just a few decades ago,
aplastic anemia can now be cured or ameliorated by stem-cell ... Cited by 139 - Related articles - BL Direct - All 12 versions
S Rosenfeld, D Follmann, O Nunez, NS … - Jama, 2003 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context In most patients, ... Cited by 123 - Related articles - BL Direct - All 4 versions
- ►hematologylibrary.org N Frickhofen, H Heimpel, JP Kaltwasser, H … - Blood, 2003 - bloodjournal.hematologylibrary.org Because HSCT cures aplastic anemia, it is the treatment of choice for young
patients with suitable stem cell donors. HLA-matched related donors are widely
accepted as stem cell donors, 2 whereas unrelated donor HSCT still carries ... Cited by 120 - Related articles - BL Direct - All 9 versions
U Testa - Leukemia, 2004 - nature.com Erythropoiesis is a complex multistep process encompassing the differentiation
of hemopoietic stem cells to mature erythrocytes. The steps involved in this
complex differentiation process are numerous and involve first the ... Cited by 85 - Related articles - All 5 versions
- ►bloodjournal.org N Hirano, MO Butler, MS von Bergwelt- … - Blood, 2003 - Am Soc Hematology Three decades ago, an immune mechanism was first implicated in the pathogenesis
of aplastic anemia (AA). 1 Since then, accumulating evidence supports the
hypothesis that immune mechanisms contribute to the pathogenesis of AA. 2-4 ... Cited by 80 - Related articles - BL Direct - All 5 versions
- ►annals.org [PDF] RA Brodsky, LL Sensenbrenner, BD Smith, D … - Annals of internal medicine, 2001 - Am Coll Physicians Background: Severe aplastic anemia is a life-threatening bone marrow failure
disorder. High-dose cyclophosphamide therapy fol- lowed by allogeneic bone
marrow transplantation cures the dis- ease. However, it requires a suitable ... Cited by 66 - Related articles - BL Direct - All 9 versions
- ►bloodjournal.org [PDF] DP Steensma, A Dispenzieri, SB Moore, G … - Blood, 2003 - Am Soc Hematology The myelodysplastic syndrome (MDS) includes a heterogeneous group of marrow
disorders characterized by ineffective hematopoi- esis and a variable risk of
leukemic transformation. Because most patients with MDS are diagnosed after ... Cited by 55 - Related articles - All 6 versions
